Generic Drug News and Research

RSS

Generic Drugs are official nonbrand names by which medicines are known. Generic names usually refer to the chemical name of the drug.

Medicare prescription drug plan for seniors and the disabled is providing substantial discounts on drugs

A study by the Kaiser Family Foundation shows that the Medicare prescription drug plan for seniors and the disabled is providing substantial discounts on drugs. In its report, the organization finds that prices have not been fluctuating as much as had been feared.

29 Jul 2004

Pharmacy Care Alliance provides $2.9 million in savings to Medicare beneficiaries

The Pharmacy Care Alliance has announced that for the first seven weeks of its discount card program, Medicare beneficiaries saved an average of 40 percent on generic drugs and 23 percent on brand drugs when compared to retail pharmacy cash prices. Medicare beneficiaries in all U.S. states have used the Pharmacy Care Alliance card since June 1.

29 Jul 2004

AstraZeneca files for patent infringement

AstraZeneca has confirmed that it has filed a lawsuit in the U.S. District Court for the District of Delaware against the generic company Andrx for patent infringement.

23 Jul 2004

Benefits from Medicare approved drug discount cards won't affect Medicaid benefits

Low-income Medicare beneficiaries who qualify for the $600 credit when they enroll in a Medicare-approved drug discount card will not have to worry that this help will be counted against them when they apply for Medicaid or other federal government benefit programs like housing and food stamps.

21 Jul 2004

Debate over acetaminophen and acute liver failure

One expert questions the acceptability of the current level of acetaminophen-related injury and death, while another suggests that acetaminophen overdoses are misunderstood.

20 Jul 2004

FDA is proposing to change the new and generic drug review process

The Food and Drug Administration (FDA) is proposing to change the new and generic drug review processes by replacing "approvable letters" and "not approvable letters" with "complete response letters" that provide companies with specific information about what needs to be done before their drugs can be approved for marketing.

20 Jul 2004

International pharmaceutical industries and governments are failing to develop and produce AIDS medicines

International pharmaceutical industries and governments are failing to develop and produce AIDS medicines and diagnostic tools suited to children, claimed Médecins Sans Frontières at the XV International AIDS Conference in Bangkok.

15 Jul 2004

Prescription drugs from bogus Canadian website are all fake

A Food and Drug Administration (FDA) analysis of three commonly prescribed drugs purchased from a Web site advertised as Canadian showed that so-called "Canadian Generics" bought from the Web site were fake, substandard and potentially dangerous.

15 Jul 2004

Four new AIDS medicines added to the World Health Organization prequalification list

Four new AIDS medicines are this week being added to the World Health Organization prequalification list, thus further increasing access to a choice of quality products.

15 Jul 2004

AIDS Healthcare Foundation targets GSK over voluntary licensing of its AIDS drug patents in South Africa

At the international AIDS conference in Bangkok, AIDS Healthcare Foundation hosted a peaceful protest against British multinational pharmaceutical giant GlaxoSmithKline over its voluntary licensing of its AIDS drug patents in South Africa.

13 Jul 2004

AIDS Healthcare Foundation, AIDS Therapeutic Treatment Now Coalition to unveil ambitious pledge at Bangkok 2004

Plans for advocacy, activism and protests throughout the weeklong AIDS conference to highlight the pressing need for increased access to life-saving anti-retroviral therapy (ARV) worldwide.

8 Jul 2004

Presidential Decree will have a direct negative impact on the health of millions of Ecuadorians

The international medical humanitarian organization Médecins Sans Frontières fears that a new Presidential Decree will make it much more difficult to obtain affordable essential medicines in Ecuador.

6 Jul 2004

Inexpensive generic fixed-dose combined therapies appears the most suitable solution for treating AIDS in developing countries

The development of simple and inexpensive generic fixed-dose combined therapies appears the most suitable solution for making possible this access to treatments in developing countries with meagre resources.

3 Jul 2004

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Combination therapy with three generic antiretroviral drugs in a single tablet has been validated for the first time in an open clinical study in a developing country. Follow-up of 60 patients treated in Yaoundé, Cameroon, has demonstrated the excellent efficacy and safety of a generic fixed-dose combination.

2 Jul 2004

Generic Drug News and Research

Further Reading

Medicare prescription drug plan for seniors and the disabled is providing substantial discounts on drugs

Pharmacy Care Alliance provides $2.9 million in savings to Medicare beneficiaries

AstraZeneca files for patent infringement

Benefits from Medicare approved drug discount cards won't affect Medicaid benefits

Debate over acetaminophen and acute liver failure

FDA is proposing to change the new and generic drug review process

International pharmaceutical industries and governments are failing to develop and produce AIDS medicines

Prescription drugs from bogus Canadian website are all fake

Four new AIDS medicines added to the World Health Organization prequalification list

AIDS Healthcare Foundation targets GSK over voluntary licensing of its AIDS drug patents in South Africa

AIDS Healthcare Foundation, AIDS Therapeutic Treatment Now Coalition to unveil ambitious pledge at Bangkok 2004

Presidential Decree will have a direct negative impact on the health of millions of Ecuadorians

Inexpensive generic fixed-dose combined therapies appears the most suitable solution for treating AIDS in developing countries

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Access to HIV antiretroviral therapies in the developing world should be a major world health priority

From potent painkillers to humble cough syrups, the same medicines that help patients misused by teens

Latin America and the Caribbean lead the developing world in providing HIV/AIDS treatment

Senior citizens cutting back on medications due to high costs

FDA to be sued by Mylan Laboratories

WHO removes two antiretroviral products from the WHO List of prequalified products

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News